Filing Details
- Accession Number:
- 0000899243-18-012922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-15 18:00:41
- Reporting Period:
- 2018-05-11
- Accepted Time:
- 2018-05-15 18:00:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896262 | Amedisys Inc | AMED | Services-Home Health Care Services (8082) | 113131700 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1679089 | B. David Pearce | 3854 American Way, Suite A Baton Rouge LA 70816 | Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-05-11 | 984 | $71.55 | 15,206 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-05-11 | 3,659 | $52.61 | 18,865 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-05-11 | 355 | $70.80 | 18,510 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-11 | 3,304 | $71.53 | 15,206 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-11 | 3,659 | $0.00 | 3,659 | $52.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,976 | 2026-07-20 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 207 | Indirect | Through 401(k) Plan |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.62 to $70.91, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.85, inclusive.
- The information in this report is based on a plan statement dated as of March 31, 2018.
- The Stock Options are subject to time-based vesting conditions. 3,659 Stock Options vested on July 20, 2017 and the remaining 10,976 Stock Options will vest in approximately equal installments on each of July 20, 2018, July 20, 2019 and July 20, 2020, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.